Search research articles
Contact Us
Filters
Showing results (11-20 of 28) with videos related to
Page
of 3
Sort By:
Bioorganic & Medicinal Chemistry Letters
|
June 6, 2006
3,4,5-Trisubstituted isoxazoles as novel PPARdelta agonists: Part 1
Robert Epple, Ross Russo, Mihai Azimioara, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 27, 2005
Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1
Hong Liu, David C Tully, Robert Epple, et al.
Journal of Medicinal Chemistry
|
January 24, 2018
Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo
Juraj Velcicky, Ursula Bodendorf, Pascal Rigollier, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 27, 2007
Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S
Arnab K Chatterjee, Hong Liu, David C Tully, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 26, 2006
3,4,5-Trisubstituted isoxazoles as novel PPARdelta agonists. Part 2
Robert Epple, Mihai Azimioara, Ross Russo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 22, 2023
Conserved reduction of m<sup>6</sup>A RNA modifications during aging and neurodegeneration is linked to changes in synaptic transcripts
Ricardo Castro-Hernández, Tea Berulava, Maria Metelova, et al.
ACS Medicinal Chemistry Letters
|
June 22, 2019
Discovery of Orally Active Hydroxyethylamine Based SPPL2a Inhibitors
Juraj Velcicky, Casey J N Mathison, Victor Nikulin, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 1, 2006
Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: heterocyclic P3
David C Tully, Hong Liu, Phil B Alper, et al.
Journal of Medicinal Chemistry
|
November 26, 2009
Novel bisaryl substituted thiazoles and oxazoles as highly potent and selective peroxisome proliferator-activated receptor delta agonists
Robert Epple, Christopher Cow, Yongping Xie, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 23, 2014
Discovery of structurally novel, potent and orally efficacious GPR119 agonists
Phil Alper, Mihai Azimioara, Christopher Cow, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 28) with videos related to
Sort By:
Page
of 3
Bioorganic & Medicinal Chemistry Letters
|
June 6, 2006
3,4,5-Trisubstituted isoxazoles as novel PPARdelta agonists: Part 1
Robert Epple, Ross Russo, Mihai Azimioara, et al.
Bioorganic & Medicinal Chemistry Letters
|
September 27, 2005
Design and synthesis of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 1
Hong Liu, David C Tully, Robert Epple, et al.
Journal of Medicinal Chemistry
|
January 24, 2018
Discovery of the First Potent, Selective, and Orally Bioavailable Signal Peptide Peptidase-Like 2a (SPPL2a) Inhibitor Displaying Pronounced Immunomodulatory Effects In Vivo
Juraj Velcicky, Ursula Bodendorf, Pascal Rigollier, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 27, 2007
Synthesis and SAR of succinamide peptidomimetic inhibitors of cathepsin S
Arnab K Chatterjee, Hong Liu, David C Tully, et al.
Bioorganic & Medicinal Chemistry Letters
|
August 26, 2006
3,4,5-Trisubstituted isoxazoles as novel PPARdelta agonists. Part 2
Robert Epple, Mihai Azimioara, Ross Russo, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 22, 2023
Conserved reduction of m<sup>6</sup>A RNA modifications during aging and neurodegeneration is linked to changes in synaptic transcripts
Ricardo Castro-Hernández, Tea Berulava, Maria Metelova, et al.
ACS Medicinal Chemistry Letters
|
June 22, 2019
Discovery of Orally Active Hydroxyethylamine Based SPPL2a Inhibitors
Juraj Velcicky, Casey J N Mathison, Victor Nikulin, et al.
Bioorganic & Medicinal Chemistry Letters
|
February 1, 2006
Synthesis and evaluation of arylaminoethyl amides as noncovalent inhibitors of cathepsin S. Part 3: heterocyclic P3
David C Tully, Hong Liu, Phil B Alper, et al.
Journal of Medicinal Chemistry
|
November 26, 2009
Novel bisaryl substituted thiazoles and oxazoles as highly potent and selective peroxisome proliferator-activated receptor delta agonists
Robert Epple, Christopher Cow, Yongping Xie, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 23, 2014
Discovery of structurally novel, potent and orally efficacious GPR119 agonists
Phil Alper, Mihai Azimioara, Christopher Cow, et al.
Page
of 3